-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Gossamer Bio, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2023 to Q2 2024.
- Gossamer Bio, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $4.44M.
- Gossamer Bio, Inc. annual Income Tax Expense (Benefit) for 2019 was $0.000.
- Gossamer Bio, Inc. annual Income Tax Expense (Benefit) for 2018 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)